Thursday, December 1, 2011

Scalp Trades Dated 1/12/2011

1. Scalp traded the following today :-











2. Congrat ! hng, your Boustead leap further. :) Certainly this will reap more profit to you if it continue to maintain the upward trend. Good luck. :)

3. Hope Dow Jones continue to move forward. :)

4. I continue to liquidate and cut my stock on hand as i hardly have time to trade at the moment. Will back in action again once my work commitment is easing. Hopefully, tomorrow sentiment continue to be good. :)

5. GAB break RM11 !! really beyond my expectation. I hope a split of shares exercise will do a lot of good to GAB's liquidity. Just a wild imagination. !! Good luck guy.


14 comments:

Anonymous said...

horse

Boustead perform just so-so compared to other GLC, particular those link to UMMO and ASB. Nevertheless, portfolio will retain boustead as major stock holding as it still trade cum 3th interim dividend of 12 sen TE. Downside risk is very limited. Portfolio also entitle to subscribe its 1 for 24, pharmaniaga share issue at 5.45, which will subsequently entitle for 1 for 10 bonus share before listing. Pharmaniaga share also is high yield dividend stock and defensive.

Furthermore, unlike other GLC, boustead have very diversify business. Invest in boustead alone give rise to various sector exposure: Manufacture and trading (UAC and BH petrol) + Plantation (BsdREITs) + Finance (Affin) + Heavy industries (Naval shipyard) + Property (The Curve + Royale Hotel chain) + Healthcare (Pharmaniaga)

For your information, boustead practice dividend payout quarterly (like Bjtoto) and have dividend policy to payout at least 70% of its net profit. Its 3th interim dividend will be ex- on 14 Dec, will follow by its final dividend in Feb, 1st interim in May and 2th interim in Sept. Total dividend is expected to be around 42-44sen, give rise to yield of 8% nett

alwayswin111 said...

Hng
very informative. thanks for the sharing.

alwayswin111 said...

Hng
what are your views on uoadev. is it worth holding at this price?

Anonymous said...

alwayswin111

UOA development movement largely very dependent on market sentiment. I'll rate UOA as good short them trading stock rather than long term holding stock.

In turn of fundamental, UOA have strong balance sheet; net cash and trading at undemanding valuation as well as below IPO price. However, as pure property player and much of the property project concentrate on Bangsar South, UOA carry larger commercial/office/service apartment market risk as demand tend to be soften in slower economic

Anonymous said...

alwayswin111

As market may pose some correction after strong runup, if UOA trade below RM 1.40, it will offer better buffer zone and higher chance to reap profit.

alwayswin111 said...

hng
Thanks a lot for taking the trouble to evaluate for me. Much appreciated.

Anonymous said...

Sold some Boustead at 5.39, realize contra profit first

Anonymous said...

Bought Uchitech at 1.15

Anonymous said...

Bought maximum Uchitech at 1.15

Anonymous said...

I think the current selling pressure on Uchitech is come from our EPF.

Fundamentally, Uchitech although report lower earning due to slower demand from Europe and appreciation of RM against its US denominate business, but Uchi still able maintain net profit margin of above 40%.

Uchi have dividend policy to payout at least 75% net profit. The payout could sometime reach as high as 85%. With limited capex and net cash position of about 39sen/share, Uchi should able ensure sustainability in dividend payout.

Current Uchi trade at fair valuation of PE 9x and cum interim dividend of 5sen TE. In short, Uchi have very attractive dividend yield of 9% nett based on interim dividend of 5sen + expected final dividend of 5.5sen to be declared in Feb.

Derick said...

hng
Thanks for sharing such a great info.

Anonymous said...

Sold off all Boustead at 5.46-5.48, realize very handsome contra gain

Anonymous said...

Bought UOA development at 1.40

Anonymous said...

Sold PJdev at 78sen, realize paper profit

Related Posts with Thumbnails